טוען...
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic
OBJECTIVE: No data are available to develop uniform recommendations for reperfusion therapies in ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to fill the evidence gap regarding STEMI reperfusion strategy during the COVID-19 era....
שמור ב:
| הוצא לאור ב: | J Int Med Res |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645389/ https://ncbi.nlm.nih.gov/pubmed/33108941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520966151 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|